Get to Know OncoSec Medical This Month, Up Close and Personal (ONCS)
OncoSec Medical Inc.
(NASDAQ:ONCS) is going to be very busy this month, taking the proverbial show on the road. Here's how and where you can catch the act.
Sep 2, 2015 7:22:14 AM PDT
James E. Brumley
If you've been wanting to learn more about OncoSec Medical Inc. (NASDAQ:ONCS) - in person - but just didn't know how, you have an answer to your question today. The company will be in attendance at several industry conferences over the course of t he next few weeks, answering questions at some of them, and presenting itself at some. These conferences ONCS will be attending are:
First World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies; Portoroz, Slovenia. Scientific Officer Dr. Robert H. Pierce will be presenting "Advances in Clinical Electroporation: Tissue Sensing, Feedback Control, and Catheter Technology" on September 9th at 4:30 PM CEST at the Grand Hotel Bernardin in Portoroz, Slovenia.
Rodman & Renshaw 17th Annual Global Investment Conference; New York, NY. President and CEO Punit Dhillon will present a corporate overview at the conference on September 9th at 10:00 AM ET, at the St. Regis Hotel in New York City.
Second Annual Global Summit on Practical and Emerging Trends in Melanoma; Pasadena, CA. Dr. Pierce will present a lecture entitled "Reversing Immune Tolerance through Intratumoral Gene Electrotransfer" during the "Emerging Technologies" session at the event, on September 19th, at 11:15 AM PT at The Langham Hotel in Pasadena.
European Cancer Congress 2015; Vienna, Austria. Shailender Bhatia, MD, from the University of Washington School of Medicine and principal investigator for OncoSec's Phase II Merkel cell carcinoma trial, will present final results from this study in an oral presentation entitled: "Intratumoral Delivery of Interleukin-12 DNA via In Vivo Electroporation Leads to Regression of Injected and Non-injected Tumors in Merkel Cell Carcinoma: Final Results of a Phase II Study" on September 27th at 6:15 PM CEST at the Messe Wien Exhibition & Congress Centre in Vienna.
Sachs 15th Annual Biotech in Europe Forum; Basel, Switzerland. President and CEO Punit Dhillon will present a corporate overview on September 30th at 11:30 AM CEST at the Congress Center Basel in Basel, Switzerland. Mr. Dhillon will also participate in an "Oncology III - Pharma/Biotech BD&L" panel on September 30th at 2:00 PM CEST.
Interested investors should note that not all of these events are open to the public. Those who wish to attend any of them should check with each conference's organizers to inquire about attending.
Either way, as is so often the case at such events, we can look for other, nuanced and new details about ONCS to emerge following these conferences. There's nothing like live events and probing questions to draw out what's not yet clear about a company and its work, and OncoSec Medical is no exception to that norm. And, either way, these events also have tendency to put a stock on a map in a bullish way, so don't be surprised if ONCS comes out of September roaring.
